Echocardiographic Changes with Positive Airway Pressure Therapy in Obesity Hypoventilation Syndrome: Long-term Pickwick Randomized Controlled Trial.
Despite a significant association between obesity hypoventilation syndrome (OHS) and cardiac dysfunction, no randomized trials have assessed the impact of long-term noninvasive ventilation (NIV) or CPAP on cardiac structure and function assessed by echocardiography. We performed a pre-specified secondary analysis of the largest multicenter randomized controlled trial of obesity hypoventilation syndrome (Pickwick project, n=221 patient with OHS and coexistent severe obstructive sleep apnea) to determine the comparative effectiveness of 3 years of NIV and CPAP on structural and functional echocardiographic changes. Conventional transthoracic two-dimensional and doppler echocardiograms were obtained at baseline and annually during 3 sequential years. Echocardiographers at each site were blinded to the treatment allocation. Statistical analysis was performed using a linear mixed-effects model with a treatment group/repeated measures interaction to determine the differential effect between CPAP and NIV. 196 patients were analysed, 102 treated with CPAP and 94 treated with NIV. Systolic pulmonary artery pressure decreased from 40.5±1.47 mmHg at baseline to 35.3±1.33 mmHg at 3 years with CPAP and from 41.5±1.56 mmHg to 35.5±1.42 with NIV (p<0.0001 for longitudinal intragroup changes for both treatment arms). However, there were no significant differences between groups. NIV and CPAP therapies similarly improved left ventricular diastolic dysfunction and reduced left atrial diameter. Both treatments led to a significant improvement in respiratory function and dyspnea. In patients with OHS who have concomitant severe obstructive sleep apnea, long-term treatment with NIV and CPAP led to similar degrees of improvement in pulmonary hypertension and left ventricular diastolic dysfunction. Clinical trial registration available at www.clinicaltrials.gov, ID: NCT01405976.